Loading...
Update on once-daily zonisamide monotherapy in partial seizures
Zonisamide is an antiepileptic drug that is structurally different from other antiepileptic agents. Its long half-life, once-daily dosing, lack of induction of hepatic enzymes, and broad spectrum of action makes it a suitable candidate for monotherapy. It has been approved as monotherapy for partial...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3964158/ https://ncbi.nlm.nih.gov/pubmed/24672240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S39152 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|